Начало・Списък с акции・Agilent Technologies Inc

Agilent Technologies Inc

Затворен

СекторЗдравеопазване

139.31 -0.27

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

138.06

Максимум

140.31

Ключови измерители
By Trading Economics
Приходи	34M 339M
Продажби	37M 1.8B
P/E Средно за сектора	27.745 64.641
EPS	1.49
Дивидентна доходност	0.73
Марж на печалбата	18.474
Служители	18,000
EBITDA	44M 500M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+12.11% upside

Дивиденти
By Acuity
Дивидентна доходност Средно за сектора	0.73% 2.31%
Следващи печалби	26.08.2026 г.
Следваща дата на дивидент	21.10.2026 г.
Следваща дата на екс-дивидент	29.09.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	6.5B 39B
Предишно отваряне	139.58
Предишно затваряне	139.31

Настроения в новините

By Acuity

16%

84%

22 / 340 Класиране в Healthcare

Agilent Technologies Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

31.07.2026 г., 20:03 ч. UTC

Agilent Technologies Inc shares are lower today, impacted by a decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

30.07.2026 г., 19:58 ч. UTC

Agilent Technologies Inc. is trading lower, continuing a decline since Wednesday's close. The Nasdaq 100 Index has increased, contrasting with Agilent's performance.

29.07.2026 г., 19:56 ч. UTC

Agilent Technologies Inc shares are lower amid broader market pressures from rising crude oil prices and inflation concerns affecting equities.

28.07.2026 г., 23:41 ч. UTC

Agilent Technologies shares declined in after-market trading, reflecting broader pressures in technology due to concerns over AI spending and competition from Chinese chipmakers.

27.07.2026 г., 22:36 ч. UTC

Agilent Technologies Inc shares are higher in after-market trading, supported by strong performance. The stock remains above its 20-day moving average.

24.07.2026 г., 19:07 ч. UTC

News

Agilent Technologies Inc shares are trading lower amid concerns over sales trends and underperformance compared to healthcare peers. The stock remains above its 20-day moving average.

23.07.2026 г., 20:03 ч. UTC

Correlated Moves

News

Agilent Technologies received EU certification for its PD-L1 IHC 22C3 diagnostic, boosting shares during Thursday's session. This marks the eighth CE-marked indication in the EU.

22.07.2026 г., 21:46 ч. UTC

Correlated Moves

Agilent Technologies Inc. is higher in after-market trading, supported by a rise in Thermo Fisher Scientific Inc. and overall life sciences sector performance.

21.07.2026 г., 20:02 ч. UTC

News

Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 assay, boosting shares as analysts express positive sentiment on its future prospects.

20.07.2026 г., 19:22 ч. UTC

News

Agilent Technologies Inc. shares are lower amid broader market declines and rising Treasury yields, despite a "Moderate Buy" consensus from analysts.

Сравнение с други в отрасъла

Ценова промяна

Agilent Technologies Inc Прогноза

Ценова цел

By TipRanks

12.11% нагоре

12-месечна прогноза

Среден 155.13 USD 12.11%

Висок 180 USD

Нисък 135 USD

Според 16 анализатори от Wall Street, предложили 12-месечна ценова цел за Agilent Technologies Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

16 ratings

Купи

Задържане

Продай

Според 16 анализатори, дали борсови рейтинги на Agilent Technologies Inc през последните 3 месеца.

Настроение

By Acuity

22 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.